The Beauty Health Company
SKIN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.04 | -0.01 | 1.50 | 0.11 |
| FCF Yield | 3.82% | 4.48% | 1.10% | 7.89% |
| EV / EBITDA | -66.02 | 14.35 | -668.38 | -146.85 |
| Quality | ||||
| ROIC | -1.45% | -0.62% | -2.14% | -1.01% |
| Gross Margin | 64.59% | 62.81% | 69.82% | 62.69% |
| Cash Conversion Ratio | -0.87 | 0.49 | -0.30 | -1.59 |
| Growth | ||||
| Revenue 3-Year CAGR | -8.90% | -7.41% | -5.05% | -2.96% |
| Free Cash Flow Growth | -10.60% | 482.98% | -88.14% | 89.83% |
| Safety | ||||
| Net Debt / EBITDA | -25.57 | 5.83 | -359.14 | -73.48 |
| Interest Coverage | -0.99 | -0.65 | -4.81 | -2.91 |
| Efficiency | ||||
| Inventory Turnover | 0.45 | 0.49 | 0.32 | 0.45 |
| Cash Conversion Cycle | 168.04 | 143.31 | 212.53 | 166.97 |